Table 1 Baseline sociodemographic characteristics and comorbidities of patients
Total | Non-prolonged LOS | Prolonged LOS | P | |
|---|---|---|---|---|
N = 434 | n = 197 (45.4%) | n = 237 (54.6%) | ||
Age, years | 69.2 ± 9.3 | 68.6 ± 9.9 | 69.6 ± 8.9 | 0.2641 |
Age, n (%) | 0.1192 | |||
< 65 years | 127 (29.3) | 65 (33.0) | 62 (26.2) | |
Gender, n (%) | 0.4192 | |||
Male | 361 (83.2) | 167 (84.8) | 194 (81.9) | |
BMI, kg/m2 | n = 420 | n = 187 | n = 233 | 0.8081 |
25.2 ± 5.7 | 25.3 ± 5.4 | 25.4 ± 5.7 | ||
Smoking status, n (%) | < 0.0012 | |||
Never smoked | 24 (5.5) | 8 (4.1) | 16 (6.8) | |
Ex-smoker | 301 (69.4) | 122 (61.9) | 179 (75.5) | |
Passive smoker | 13 (3.0) | 5 (2.5) | 8 (3.4) | |
Active smoker | 96 (22.1) | 62 (31.5) | 34 (14.3) | |
Biomass exposure, n (%) | < 0.0012 | |||
Yes | 188 (43.3) | 64 (32.5) | 124 (52.3) | |
Comorbidity, n (%) | 0.0162 | |||
Yes | 356 (82.0) | 152 (77.2) | 204 (86.1) | |
LTOT, n (%) | 0.0012 | |||
Yes | 202 (46.5) | 75 (38.1) | 127 (53.6) | |
NIMV, n (%) | 0.0182 | |||
Yes | 95 (21.9) | 33 (16.8) | 62 (26.2) | |
Nebulizer use, n (%) | 0.0282 | |||
Yes | 286 (65.9) | 119 (60.4) | 167 (70.5) | |
HAD (total point) | n = 399 | n = 176 | n = 223 | < 0.0013 |
16.0 (11.0–22.0) | 15.0 (8.0–19.0) | 18.0 (12.0–23.0) | ||
HAD, n (%) | n = 399 | n = 176 | n = 223 | 0.0082 |
≥ 16 (median) | 220 (55.1) | 84 (47.7) | 136 (61.0) | |
Stop Bang, n (%) | n = 405 | n = 180 | n = 225 | 0.0062 |
Low risk for OSA | 83 (20.5) | 31 (17.2) | 52 (23.1) | |
Intermediate risk for OSA | 187 (46.2) | 99 (55.0) | 88 (39.1) | |
High risk for OSA | 135 (33.3) | 50 (27.8) | 85 (37.8) | |
Comorbidities | ||||
Heart Failure, n (%) | 0.0072 | |||
Yes | 106 (24.4) | 36 (18.3) | 70 (29.5) | |
Arrhythmia, n (%) | 0.0142 | |||
Yes | 74 (17.1) | 24 (12.2) | 50 (21.1) | |
CRF, n (%) | 0.0122 | |||
Yes | 37 (8.5) | 9 (4.6) | 28 (11.8) | |
Lung Cancer, n (%) | 0.0042 | |||
Yes | 22 (5.1) | 3 (1.5) | 19 (8.0) |